Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy

Fig. 2

The spectrum and frequency of sequential somatic mutations in 108 CRC patients. The most common sequential somatic mutation was germline mutation. TP53 occurred 76 times in our cohort. TP53, APC occurred 67 times. Germline, APC occurred 60 times. Only sequential somatic mutations that occurred at least 15 times are shown in the plot

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us